Compare NVR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVR | HOLX |
|---|---|---|
| Founded | 1980 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9B | 16.9B |
| IPO Year | 1995 | 1995 |
| Metric | NVR | HOLX |
|---|---|---|
| Price | $6,188.11 | $76.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 13 |
| Target Price | ★ $7,157.80 | $77.89 |
| AVG Volume (30 Days) | 14.6K | ★ 48.6M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 436.55 | 0.79 |
| Revenue | ★ $10,323,959,000.00 | $4,100,500,000.00 |
| Revenue This Year | N/A | $4.74 |
| Revenue Next Year | $6.60 | $5.03 |
| P/E Ratio | ★ $14.48 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $6,195.15 | $51.90 |
| 52 Week High | $8,618.28 | $76.07 |
| Indicator | NVR | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 34.94 | 69.09 |
| Support Level | N/A | $75.10 |
| Resistance Level | $7,778.36 | N/A |
| Average True Range (ATR) | 196.39 | 0.19 |
| MACD | -56.56 | 0.03 |
| Stochastic Oscillator | 0.00 | 95.19 |
NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.